glp 1 drugs GLP-1 Agonists: A Comprehensive Overview Could GLP-1 Drugs Lower Epilepsy
Description
A Danish study from 2022, which administered exenatide the drug developed from the Gila monster found no broad differences in cravings or drinking reduction between those on the drug and those on a placebo
Front Endocrinol (Lausanne) 2023;14:1215356
The good news is that you may be able to prevent or delay Type 2 diabetes with healthy lifestyle changes
Consequently, apparent reductions in colorectal or liver cancer risk should not be interpreted as evidence of cancer prevention but rather as signals warranting further investigation
